Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced its third significant…
Read More
Eli Lilly’s Retatrutide Demonstrates Unprecedented Weight Loss with Notable Side Effect Profile in Phase 3 Trials
Eli Lilly and Company’s investigational drug, retatrutide, a groundbreaking triple hormone receptor agonist, has delivered an average weight loss of…
Read More
BioNTech’s Post-Pandemic Pivot: From €19 Billion Vaccine Bonanza to Oncology’s €16.8 Billion Bet Amidst Job Cuts and Shifting mRNA Landscape
The German biotechnology firm BioNTech, a name synonymous with the rapid development of the world’s first widely authorized mRNA COVID-19…
Read More
Deloitte report showed pharma returns rising to 7%. GLP-1s did most of the work.
After a period of post-pandemic uncertainty and uneven growth, a closely monitored metric of biopharmaceutical research and development (R&D) productivity…
Read More
Canada Becomes First G7 Nation to Approve Generic Semaglutide as Novo Nordisk Patent Lapses
In a landmark decision poised to reshape the pharmaceutical landscape and significantly impact patient access and healthcare costs, Health Canada…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The biotechnology sector is experiencing a significant resurgence, marked by a robust recovery in public markets and an explosion in…
Read More
BD and Wellstar Forge AI-Powered Alliance for End-to-End Medication Management
BD (Becton, Dickinson and Company), a leading global medical technology company, has announced a strategic partnership with Wellstar Health System,…
Read More
FDA Commissioner Marty Makary Resigns Amid Pressure and Widespread Criticism
Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, effective immediately, following escalating rumors that President…
Read More
Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer
The landscape of lung cancer treatment has undergone a significant transformation with the advent of immunotherapy, particularly checkpoint inhibitors, offering…
Read More
Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior
Cellular Intelligence, a rapidly emerging biotech firm previously known as Somite AI, has secured global rights to a pioneering clinical-stage…
Read MoreYOU MAY HAVE MISSED
